Stellungnahme zu EBA Guidelines on the treatment of CVA risk under the supervisory review and evaluation process (SREP) - (EBA/CP/2015/21)
- archived
- 1 minute reading time
GBIC Comments on EBA Guidelines on the treatment of CVA risk under the supervisory review and evaluation process (SREP)
Continue reading with a PwC Plus-Subscription
- verified Information source
- daily updates
- completely searchable articles (with refiner)
- tailored alert